These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 26247733)

  • 21. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.
    Zheng Y; Gierut J; Wang Z; Miao J; Asara JM; Tyner AL
    Oncogene; 2013 Sep; 32(36):4304-12. PubMed ID: 23027128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten.
    Barbieri I; Pensa S; Pannellini T; Quaglino E; Maritano D; Demaria M; Voster A; Turkson J; Cavallo F; Watson CJ; Provero P; Musiani P; Poli V
    Cancer Res; 2010 Mar; 70(6):2558-67. PubMed ID: 20215508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alcohol promotes mammary tumor development via the estrogen pathway in estrogen receptor alpha-negative HER2/neu mice.
    Wong AW; Dunlap SM; Holcomb VB; Nunez NP
    Alcohol Clin Exp Res; 2012 Apr; 36(4):577-87. PubMed ID: 21981381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis.
    Shepherd TG; Kockeritz L; Szrajber MR; Muller WJ; Hassell JA
    Curr Biol; 2001 Nov; 11(22):1739-48. PubMed ID: 11719215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis.
    Patel Y; Soni M; Awgulewitsch A; Kern MJ; Liu S; Shah N; Singh UP; Chen H
    Oncogene; 2019 Jan; 38(3):445-453. PubMed ID: 30104710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Utero Exposure to Bisphenol a Promotes Mammary Tumor Risk in MMTV-Erbb2 Transgenic Mice Through the Induction of ER-erbB2 Crosstalk.
    Ma Z; Parris AB; Howard EW; Davis M; Cao X; Woods C; Yang X
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32353937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression.
    Hutchinson J; Jin J; Cardiff RD; Woodgett JR; Muller WJ
    Mol Cell Biol; 2001 Mar; 21(6):2203-12. PubMed ID: 11238953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein-tyrosine kinase 6 promotes peripheral adhesion complex formation and cell migration by phosphorylating p130 CRK-associated substrate.
    Zheng Y; Asara JM; Tyner AL
    J Biol Chem; 2012 Jan; 287(1):148-158. PubMed ID: 22084245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p130Cas is an essential transducer element in ErbB2 transformation.
    Cabodi S; Tinnirello A; Bisaro B; Tornillo G; del Pilar Camacho-Leal M; Forni G; Cojoca R; Iezzi M; Amici A; Montani M; Eva A; Di Stefano P; Muthuswamy SK; Tarone G; Turco E; Defilippi P
    FASEB J; 2010 Oct; 24(10):3796-808. PubMed ID: 20505116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
    Ursini-Siegel J; Rajput AB; Lu H; Sanguin-Gendreau V; Zuo D; Papavasiliou V; Lavoie C; Turpin J; Cianflone K; Huntsman DG; Muller WJ
    Mol Cell Biol; 2007 Sep; 27(18):6361-71. PubMed ID: 17636013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium.
    Ip MM; McGee SO; Masso-Welch PA; Ip C; Meng X; Ou L; Shoemaker SF
    Carcinogenesis; 2007 Jun; 28(6):1269-76. PubMed ID: 17259656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.
    Wellberg EA; Johnson S; Finlay-Schultz J; Lewis AS; Terrell KL; Sartorius CA; Abel ED; Muller WJ; Anderson SM
    Breast Cancer Res; 2016 Dec; 18(1):131. PubMed ID: 27998284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.
    Sriram R; Lo V; Pryce B; Antonova L; Mears AJ; Daneshmand M; McKay B; Conway SJ; Muller WJ; Sabourin LA
    Breast Cancer Res; 2015 Jan; 17(1):7. PubMed ID: 25592291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
    Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B
    Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice.
    Hodgson MC; Vanostran G; Alghamdi S; Poppiti RJ; Agoulnik AI; Agoulnik IU
    PLoS One; 2013; 8(4):e60455. PubMed ID: 23593223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer.
    Allen-Petersen BL; Carter CJ; Ohm AM; Reyland ME
    Oncogene; 2014 Mar; 33(10):1306-15. PubMed ID: 23474764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ErbB2 activation and signal transduction in normal and malignant mammary cells.
    Hynes NE
    J Mammary Gland Biol Neoplasia; 1996 Apr; 1(2):199-206. PubMed ID: 10887493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors.
    Basak P; Leslie H; Dillon RL; Muller WJ; Raouf A; Mowat MRA
    Genes Chromosomes Cancer; 2018 Apr; 57(4):182-191. PubMed ID: 29218825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stat1 is a suppressor of ErbB2/Neu-mediated cellular transformation and mouse mammary gland tumor formation.
    Raven JF; Williams V; Wang S; Tremblay ML; Muller WJ; Durbin JE; Koromilas AE
    Cell Cycle; 2011 Mar; 10(5):794-804. PubMed ID: 21311224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of simultaneous knockdown of HER2 and PTK6 on malignancy and tumor progression in human breast cancer cells.
    Ludyga N; Anastasov N; Rosemann M; Seiler J; Lohmann N; Braselmann H; Mengele K; Schmitt M; Höfler H; Aubele M
    Mol Cancer Res; 2013 Apr; 11(4):381-92. PubMed ID: 23364537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.